Equities analysts expect that Iqvia Holdings Inc (NYSE:IQV) will announce sales of $2.44 billion for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Iqvia’s earnings, with the highest sales estimate coming in at $2.45 billion and the lowest estimate coming in at $2.43 billion. Iqvia posted sales of $1.91 billion in the same quarter last year, which would indicate a positive year over year growth rate of 27.7%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, May 2nd.
On average, analysts expect that Iqvia will report full year sales of $2.44 billion for the current financial year, with estimates ranging from $10.11 billion to $10.16 billion. For the next fiscal year, analysts expect that the firm will report sales of $10.48 billion per share, with estimates ranging from $9.00 billion to $10.82 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of analysts that cover Iqvia.
Iqvia (NYSE:IQV) last posted its earnings results on Wednesday, February 14th. The medical research company reported $1.32 EPS for the quarter, missing the consensus estimate of $1.34 by ($0.02). Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The business had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.14 billion. During the same quarter in the prior year, the business earned $1.09 earnings per share. The firm’s quarterly revenue was up 10.7% on a year-over-year basis.
Shares of Iqvia (NYSE IQV) opened at $105.93 on Tuesday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 1.21. Iqvia has a 1 year low of $76.80 and a 1 year high of $110.67. The company has a market cap of $22,030.00, a P/E ratio of 70.62, a P/E/G ratio of 2.70 and a beta of 0.64.
In other news, Director Michael J. Evanisko sold 816 shares of Iqvia stock in a transaction on Monday, March 5th. The shares were sold at an average price of $100.00, for a total value of $81,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider James H. Erlinger III sold 10,000 shares of Iqvia stock in a transaction on Wednesday, January 17th. The shares were sold at an average price of $99.97, for a total transaction of $999,700.00. The disclosure for this sale can be found here. Insiders sold a total of 30,816 shares of company stock valued at $3,093,400 in the last quarter. 6.00% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the company. Franklin Street Advisors Inc. NC bought a new stake in shares of Iqvia in the 4th quarter valued at $7,446,000. Chevy Chase Trust Holdings Inc. bought a new stake in shares of Iqvia in the 4th quarter valued at $14,462,000. Icon Advisers Inc. Co. bought a new stake in shares of Iqvia in the 4th quarter valued at $852,000. BlackRock Inc. bought a new stake in shares of Iqvia in the 4th quarter valued at $942,532,000. Finally, Nisa Investment Advisors LLC bought a new stake in shares of Iqvia in the 4th quarter valued at $920,000. Institutional investors own 92.34% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “$2.44 Billion in Sales Expected for Iqvia Holdings Inc (IQV) This Quarter” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3258414/2-44-billion-in-sales-expected-for-iqvia-holdings-inc-iqv-this-quarter-2.html.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.